Running title: Resveratrol attenuates sarcopenic obesity.
Introduction
Sarcopenic obesity is the combination of sarcopenia and obesity. Some key age-and obesity-mediated factors and pathways may aggravate sarcopenia.
Sarcopenia is an age-associated skeletal muscle mass loss coupled with functional deterioration exacerbated by obesity (1) . To reflect the direction of the pathological pathway from "sarcopenia→obesity" to "obesity → sarcopenia" be defined as "Sarcopenic obesity". Over Adipocytes in skeletal muscle tissue are leading to premature tissue aging (2, 3) . Obesity in adulthood is a medical condition in which excess body fat has accumulated leading to reduced lower skeletal muscle mass and strength with potential implications for developing sarcopenic obesity increased health problems (4, (5) (6) . We hypothesize that resveratrol treatment in male mice programmed by obesity-induced sarcopenia and aging-associated sarcopenia would prevent skeletal muscle atrophy and muscle mass decreases. The prevalence of obesity in the whole word is increasing in all age groups. Since sarcopenia is directly attributed to obesity or age, there's no guarantee that a person will be able to prevent it (7, (10) (11) .
Obesity is most commonly caused by a combination of excessive food energy intake, not exercising enough, age, smoking or heavy alcohol use, although a few caused by genes (12) . Obesity is associated with skeletal muscle loss and impairgenesis. Increased infiltration of proinflammatory in skeletal muscle strophy is noted in obesity and sarcopenia and is associated with muscle dysfunction (13, (14) (15) (16) . Sarcopenia is now recognized as a disease, most common in older people, but can also occur earlier in life (17) . As we grow older, up to half of the muscle is lost and skeletal muscle is often replaced with fat tissue, particularly in sarcopenia. There are several factors contributing to the disorder such as lack of exercise, and poor nutrition (18) . Resveratrol is a phytoalexin polyphenolic compound derived from naturally grapes, red wine and other food products with antioxidant activities and antiaging properties (19, 20) . Resveratrol rely on into the blood circulation of trans-reveratrol to achieve. Resveratrol has beneficial effects on enhance the complex deficiency of immune system, correction the biochemical defect in oxygen consumption, reduce the risk of cardiovascular disease, inhibition inflammation and platelet aggregation and improve degenerative Alzheimer's disease (21, (22) (23) (24) . In this study, we investigated the peripheral immune-regulating potential of resveratrol against HFD-induced apoptosis by restoring mitochondrial functional activities, and stimulating mitochondrial biogenesis. Resveratrol and exercise training is a highly effective strategy to offset sarcopenia (25). Exercise training improves the vasodilatory properties of the vasculature thereby optimizing O2 transport throughout the body to improve vascular function in association with the reduction of reactive oxygen species (26). Blood flow is markedly increased in contracting skeletal muscles and myocardium. Habitual exercise training alone did not elicit mitochondrial dysfunction improvements in healthy aged subject, may be have to combined with resveratrol intake in aging-associated function decline (27, (28) (29) (30) (31) (32) . Therefore, we determine the effect of resveratrol, exercise training, and combined exercise training with resveratrol intake on agedependent sarcopenia. And to determine the effect of resveratrol on obesityinduced sarcopenia or age-dependent sarcopenia in sarcopenic obesity health.
Materials and methods

Obesity animal model
We purchased 46 male C57BL/6J mice at ages 6 weeks from BioLASCO Taiwan Co., Ltd. C57BL/6J mice (N=39) were fed a high-fat diet (HFD) for 5 weeks to induce obesity, and then were assigned to three groups containing low-(50 mg/Kg BW, N=10), middle-(100 mg/Kg BW, N=10) and high-(200 mg/Kg BW, N=9) dose of resveratrol and 0.2 % pubucol (N=10) for 4 weeks. The HFD group received a high-fat diet, and the HFD+LR group received a low-dose resveratrol (LR)-containing HFD, the HFD+MR group received a middle-dose resveratrol (MR)-containing HFD, the HFD+HR group received a high-dose resveratrol (HR)-containing HFD and 0.2 % pubucolcontaining HFD. After additional feeding of the experimental diet for 4 weeks, mice in the HFD group were highly obese compared with the mice in the standard diet fed mice group. The use of animals in our experimental design was approved by the Animal Care and Use Committee of Taipei Medical University. Adult mice were housed five per cage in a temperature-controlled room (24 ± 1℃) with a 12-h light/dark cycle (06.30a.m. to 18.30p.m.). Mice were fed commercial laboratory chow and water ad. lib. Animals were killing after 4
week experimental. The skeletal muscles were collected for dissection of muscle mass and detected the skeletal muscle to quantify mitochondrial function and aging-related disease signaling proteins by Western blotting. We also dissected and weighed of white adipose tissue to analyze adiposity, besides body protein body fat (%) content analysis by muscle drying weight (mg)/fat weight (mg). All experimental procedures were approved by the Animal Care and Use Committee of Taipei Medical University, and all animal experiments were performed in accordance with the ARRIVE guidelines and use of laboratory animals.
Experimental design in sarcopenia animal model.
Threety-one male adult senescence-accelerated mice (SAMP8) of 3 months of age weighting 35 g were used in this study (total N=31). We examined the effect of exercise training, resveratrol and their combination on the prevention of sarcopenia using a senescence-accelerated-prone mice (SAMP8) model. Animals were divided into four experimental groups: non-treated SAMP8 control groups (SAMP8, N=8), exercise training SAMP8 groups (SAMP8+Ex, N=8), resveratrol intake SAMP8 groups (SAMP8+ Re, 150 mg/Kg BW, N=10) (N=7) and combination exercise training and resveratrol intake SAMP8 groups (SAMP8+Ex+Re, N=8). Mice were housed in two cage of one group for all experimental process before sacrificed. Mice maintained in a room at 22±2 °C, After skeletal muscle perfusion fixation with buffered formalin for 15min, the skeletal muscle was sectioned into six equal transverse slices starting from the apex to base. Two of these sections were embedded in paraffin. The remaining sections were cut at 6μm thickness and stained with H&E stain. Slides were deparaffinized and dehydrated. Samples were passed through a series of graded alcohols from 100% to 90% to 70%, 5min each. The skeletal muscle sections were processed for fibrosis quantification. H&E staining were prepared one of two sections and incubated for 5min at room temperature. The other of two sections were treated to TUNEL assay (Apoptosis detection kit, TA300, R&D Systems, Minneapolis, MN, USA). After rinsing with phosphate-buffered saline (PBS), each slide was then soaked with 85% alcohol, 100% alcohol for 15min. Stained sections were rinsed with PBS and air dried before mounting.
Cross-sections were H&E stained and TUNEL assay. Color images of crosssections were made at 200x total magnification using a Nikon E600.
Microscope lighting was optimized and increased the probability of being visualized in appropriate cross-sections and not-tangentially. The number of TUNEL-positive cells per muscle area was counted in 20 visual fields (magnification 400×) for each mice.
Western blotting analysis
The skeletal muscle cut in small pieces in PBS buffer homogenized in a homogenizer and then centrifuged at 12,000 ×rpm for 30min at 4°C. Washed the immunoblots three times in 5ml blotting buffer for 5min and afterwards PVDF were incubated with secondary antibody solution containing Horseradish peroxidase-conjugated anti-rabbit (1:1000), anti-goat (1:500), or anti-mouse (1:1000) IgG secondary antibodies (Santa Cruz Lab, CA) for 1hr at room temperature. Secondary antibodies were used for ECL chemiluminescent (Sigma-Aldrich, Bornem, Belgium) detection of proteins. When required, blots were reprobed after stripping in 62.5mM Tris-HCl (pH 6.8), 2%SDS, and 100 mMβ-mercaptoethanol at room temperature for 30min, blocked and reprobed with polyclonal or monoclonal antibody. Membranes were scanned and quantified with Image J Imagine program software.
Statistical analysis
Quantitation was carried out by analyzing the intensity of the hybridization signals using ImageJ Imagine program for western blot analysis. Obesity (HFDfed mice) data was obtained from at least two independent experiments.
Statistical analysis of the data was normalized to the values of the group of the same batch expressed as a mean ± standard error of the means (SEM) using SigmaStat software. * p < 0.05, ** p < 0.01 significant differences compared with control group, # p < 0.05, ## p < 0.01 significant differences compared with SAMP8 without treatment group. Sarcopenia (SAMP8 mice) data was obtained from at least three independent experiments. Statistical analysis of the data was performed to the values of the control group of the same batch using SigmaStat 11.0 software. Results were expressed as mean ± SEM. Two-group comparisons were carried out with the Student's t test. Differences were considered significant at * p < 0.05 and ** p < 0.01.
Results
Resveratrol prevents age-related changes in the body and skeletal muscle composition in sarcopenia in adults with obesity and SAMP8 mice.
In adults with obesity, sarcopenia is associated with lower muscle mass and strength and a greater likelihood of occurrence sarcopenia obesity. C57BL/6J mice fed high-fed diet (HFD) to induce obesity, body drying weight (mg), muscle drying grinding (mg), fat weight (mg) and body fat (%) were investigated.
Results showed body drying weight-HFD groups mean ± SEM. (6.98417 ± 1.135715 (mg), p=0.030959) was increased compared to control (5.94437 ± 0.70812 (mg)). Resveratrol intake during HFD-fed was no significant difference compared to HFD groups. Compared to control, all of dose resveratrol lead to body drying weight increases (Table 1) . Bodyweight drying weight is skeletal muscle and fat couple together. Skeletal muscle drying grinding-HFD groups mean ± SEM. (6.98417 ± 1.135715 (mg), p=0.040394) was increased compared to control (5.76293 ± 0.74955 (mg)). High-dose resveratrol containing HFD (HFD+HR (200 mg/Kg)) groups mean ± SEM. (7.01058 ± 0.59543 (mg), p=0.14457) was a little skeletal muscle increases compared to HFD groups (6.59688 ± 0.912178 (mg)) ( Table 2 ). In contrast, low-dose resveratrol containing HFD (HFD+LR (50 mg/Kg)) (1.30442 ± 0.420315 (mg), p=0.058043) groups and middle-dose resveratrol containing HFD (HFD+MR (100 mg/Kg)) (1.11554 ± 0.451432 (mg), p=0.017555) of fat weight (mg) has significant difference decreases, when compared to HFD (1.76943 ± 0.73303 (mg)) groups ( Table 4 ). Taken a together, in adulthood obesity independent predictor of lower skeletal muscle mass and high-fat weight with potential implication for sarcopenia in adults with obesity. Resveratrol can make skeletal muscle mass increases and lower fat weight during sarcopenia in adults with obesity development. On aging-related skeletal muscle atrophy, we use senescence-accelerated mice (SAMP8) to investigate the growing recognition of sarcopenia. Results showed in SAMP8 mice, the age-related loss of skeletal muscle mass, exercise training, resveratrol intake, and their combination grow or maintain skeletal muscle mass ( Fig. 1A) . Age-related sarcopenia induced skeletal muscle fiber disorder in SAMP8 mice. Exercise training, resveratrol intake, and their combination ameliorated the increase in slow skeletal muscle fibers in the SAMP8 mice ( Fig. 1B and 1C ). Sarcopenia recognized muscle-wasting condition is suffering from a major of cell apoptosis.
Cell apoptosis was observed using TUNEL staining ( Fig. 1D ). Exercise training, resveratrol intake, and their combination alleviated cell apoptosis in skeletal muscle sarcopenic SAMP8 mice ( Fig. 1D and 1E ). We demonstrate for the first time that resveratrol has a therapeutic effect against skeletal muscle sarcopenia.
Resveratrol counteracts obesity and aging-associated decline of mitochondrial biogenesis and function in skeletal muscles of HFD-fed mice and sarcopenic skeletal muscles SAMP8 mice.
Consumption of high-fat diet (HFD) is related with increased dysfunctional mitochondria in skeletal muscles. Thus, in order to determine mitochondria function, we detected mitochondrial protein populations in high-fat diet (HFD)induced obesity mice. Results showed us high-fat diet (HFD)-induced obesity augments skeletal muscle atrophy by induction of protein degradation in the mitochondria (Fig. 2) . High-dose of the anti-adipogenic agents resveratrol preserved mitochondrial activity in skeletal muscle from mice with high-fat diet (HFD)-induced obesity ( Fig. 2A) . High-dose of resveratrol has a significant Skeletal muscle ECM remodeling occurs to HFD-induced obesity with as skeletal muscle mass gain ( Table 1 and Table 2 ). MMP2 and MMP9 upregulation enhanced activity in obesity skeletal muscle atrophy (p<0.05).
Resveratrol is only slightly elevated in MMP9 HDF-induced skeletal muscle (Fig.   3A ). Low-dose resveratrol-containing HFD (HFD+LR) and middle-dose resveratrol-containing HFD (HFD+MR) groups has a significant difference compared to control (p<0.05). MMP9 up-regulation appears to be an important additional molecular event in the multistep process of all inflammatory myopathies. The results provide a potential interventional strategy for controlling inflammatory response by supplementing resveratrol. In adipose tissue, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) increase the release of free fatty acids from adipose tissue. Obesity in adipose tissue induced by high-fat diet is associated with impaired natriuretic peptide release leading to a significant reduction of systemic natriuretic peptide expression levels. In skeletal muscle tissue, high-fat diet is a little difference increases by ANP and BNP. The actions of BNP are mediated via the ANP receptors, the physiologic effects of BNP are identical to those of ANP.
Resveratrol intake lower ANP and BNP protein synthase was found to be a predictor of survival in high-fat diet-induced obesity sarcopenia skeletal muscle ( Fig. 3B ). Resveratrol was minimally altered by HFD-diet induced obesity sarcopenia. MMP2 and MMP9 are involved in aging physiological processes such as skeletal muscle development and maturation. Degeneration of skeletal muscle MMP2 and MMP9 with age contributed to functional decline in sarcopenia SAMP8 mice (Fig. 3C) . Exercise training did not reverse these changes. In order for exercise training to be effective, proper nutrition must be in place. Resveratrol intake plays a major role in preventing sarcopenia. Results showed resveratrol intake and exercise training supplements resveratrol intake can contributed skeletal muscle MMP2 and MMP9 with age increases (p<0.05 and p<0.01, respectively). Furthermore, to show the potential for fibroblast growth factor (FGF2) and Urokinase-type plasminogen activator (UPA) to affect skeletal muscles. Exercise training remained FGF2 and UPA activities unchanged. FGF2 is involved in muscle mass modulation. Both growth factors of FGF2 and UPA activities enhance the reinnervation of muscle. Thus, exercise training, resveratrol intake, and exercise training supplements resveratrol intake no effects on FGF2 and UPA activities (Fig. 3D) . Exercise training and resveratrol intake treatment with FGF2 and UPA causes skeletal muscle hypertrophy in SAMP8 mice.
Resveratrol protected against skeletal muscle atrophy and inflammatory myopathies induced by obesity and sarcopenia.
High-fat diet (HFD) induced obesity has deleterious effect on skeletal muscle atrophy and is associated with low-grade chronic inflammation. On the molecular level, HFD-induced obesity inhibited PI3K/Akt pathway in skeletal muscles of HFD-fed mice (p<0.05). Resveratrol intake in spite of low-, middle-, or high-dose was activated PI3K/Akt pathway in skeletal muscles of HFD-fed mice ( Fig 4A) . Resveratrol intake was to be a promising material to alleviate HFD-induced muscle atrophy. Obesity is associated with chronic inflammation after adjustment for aging. Chronic inflammation occurs in skeletal muscle in obesity is mainly manifested by increased immune cell infiltration and proinflammatory activation in intermyocellular and perimuscular adipose tissue.
Thus, skeletal muscle inflammation showed distinct patterns of up-regulation of IL-6 and STAT3 in skeletal muscles of HFD-fed mice (Fig. 4B) (p<0.05) . Highdose resveratrol in HFD-fed mice (HR-HFD) and Pubucol has significant lower expression levels by IL-6 (p<0.05). STAT3 was a slight increase in skeletal muscle inflammation. Thus, resveratrol in HFD-fed mice (HR-HFD) has no significant difference by STAT3. Taken together, resveratrol alleviated adulthood obesity-induced sarcopenia in skeletal muscles of HFD-fed mice.
Furthermore, we determine whether resveratrol could alleviate age-related sarcopenia in skeletal muscle SAMP8 mice. Age-associated with sarcopenia is a disease of muscles in which skeletal muscle atrophy and inflammatory myopathies. Age-associated with sarcopenia can be slightly mitigated, if not outright managed, with exercise and nutrition. Intriguingly, young adult SAMP8 mice with slight sarcopenia were no effects by exercise training. In this study, we only find resveratrol has good effects against skeletal muscle atrophy and inflammatory myopathies ( Fig. 4C and 4D ). We found protein expression of Resveratrol prevented the exacerbation of skeletal muscle atrophy (Fig. 6A ).
After intake in spite of low-, middle-, and high-dose resveratrol, NFATc3 was a little increase to cause hypertrophy and prevent atrophy. In contrast, ERK1/2 was not activated during HFD-induced skeletal muscle atrophy (Fig. 6B) (p<0.05). Low-, middle-, and high-dose resveratrol, activation of ERK1/2 can oppose skeletal muscle atrophy induced by disuse. For skeletal muscle facing aging populations, sarcopenia lead to a loss in the mass and size of our muscles in SAMP8 mice. Sarcopenia has been associated with impaired skeletal muscle hypertrophy. Exercise training a little reverse muscle atrophy occurred to NFATc3 increases (Fig. 6C ). Resveratrol and their combination was not found good effects on skeletal muscle hypertrophy or atrophy. In sarcopenic skeletal muscle SAMP8 mice, ERK1 protein expression did not have significant difference by exercise training (Fig. 6D ). Resveratrol and their combination has significant difference by ERK1 (p<0.05). Exercise and proper nutrition help battle this disease. Therefore, resveratrol protected against skeletal muscle atrophy and inflammatory myopathies induced by obesity and sarcopenia.
Discussion
The aging of the population represents one of the largest healthcare challenges facing the world today. Some papers has reported to lower the rate of production of free radical reaction damage have been shown to increase the life span, to enhance mitochondrial function and age-mediated immune responses and to slow development of sarcopenia and the skeletal muscles disorders (33, (34) (35) (36) (37) . We examined the effects of resveratrol, a natural polyphenolic compound present in grapes, on sarcopenia obesity in (high-fat diet (HFD)-induced obesity mice and aging-associated sarcopenia SAMP8 mice. The resveratrol theory of aging provides reasonable explanations for ageassociated sarcopenica (38) . In addition, studies strongly suggest that resveratrol play a significant role in the deterioration of skeletal muscle with obesity and sarcopenia with age-associated phenomena (39) . It was found in this study that HFD-fed mice with resveratrol during obesity-sarcopenia could improve skeletal muscle mass ( Table 1 and Table 2 ) and inhibited fat weight ( Table 3 and Table 4 ). Adipose tissue extra lipids cannot be accumulated in the adipose tissue much longer, does infiltrate into peripheral organs such as the skeletal muscle cause dysfunction of the organs (40, 41) . Deleterious effects of aging probably reflecting on skeletal muscle mass (Fig. 1A) , space ( Fig. 1B and   1C ), and cell apoptosis ( Fig. 1D and 1E ). Furthermore, expression levels of mitochondrial biogenesis and function, muscle hypertrophic process following atrophy, and skeletal muscle atrophy and inflammatory myopathies in skeletal muscle tissue from two different mice models of high-fat diet (HFD)-induced obesity mice and aging-associated sarcopenia SAMP8 mice were detected by western blot. Resveratrol has been reported to target mitochondrial-related pathways in two different animal models ( Fig. 2 and Fig. 3 ). Exercise training does not play a role in regulating skeletal muscle mitochondrial dysfunction, inflammatory myopathies, and muscle hypertrophic process during agingrelated atrophy (sarcopenia) (Fig. 2, Fig. 3, Fig. 4, Fig. 5 and Fig. 6 ). In general, resveratrol has also been shown to exhibit antioxidant, anti-inflammatory, antiproliferative properties and to decrease collage synthesis in two skeletal muscle type animal models. Therefore, resveratrol is currently advised as supplement in the diet of elderly individuals. Sarcopenic obesity results in skeletal muscle and fat replacement, resveratrol which prevent skeletal muscles atrophy from obesity or sarcopenia (42) . Resveratrol induces mediates anti-inflammatory effects and inhibits skeletal muscles atrophy. (Fig. 4 and Fig. 5 ). Moreover, matrix metalloproteinases (MMPs) in inflammatory myopathies enhanced immunoreactivity near atrophic myofibers (43) . MMP-9 was strongly expressed in atrophic myofibers in all inflammatory myopathies. MMP-2 immunoreactivity is only slightly elevated in inflamed muscle. (Fig. 3A and 3C ). ANP and BNP binding to the natriuretic peptide receptor A (NPRA) rising intracellular cGMP levels induce expression of downstream genes in skeletal muscle (44) . Free fatty acids from adipocyte lipolysis serve as additional ligands for the transcriptional regulator of mitochondrial biogenesis. Thus, resveratrol increase skeletal muscle mitochondrial content (Bcl2, PI3K/Akt) ( Fig. 2 and Fig. 4 ) and skeletal muscle reverse atrophy, but not hypertrophy (FGF2/UPA and NFATc3/ERK1/2) ( Fig. 3 and Fig. 6 ). A novel function of FGF-2 in regulating skeletal muscle mass through enlargement of muscle fiber size, while physiological and pharmacological doses, treatment with FGF-2 causes skeletal muscle hypertrophy in mice, to protect muscle from atrophy (45, (46) (47) . JNK/p38-mediated intrinsic pathway signaling is one of the mechanisms involved in age-related increase in muscle cell apoptosis (48, (49) (50) . Protective effect of resveratrol against inflammation on progressive skeletal muscle atrophy also be observed in obesity-induce sarcopenia mice and age-related sarcopenia SAMP8 mice. Data are expressed as mean ± SEM. * p<0.05, ** p<0.01, significant difference compared with SAMP8 mice without treatment. NS. was expressed no significant difference. SAMP8; SAMP8 control groups, SAMP8+Ex; exercise training SAMP8 groups, SAMP8+ Re; resveratrol intake SAMP8 groups, SAMP8+Ex+Re; combination exercise training and resveratrol intake SAMP8 groups. Data are expressed as mean ± SEM. * p<0.05, significant difference compared with SAMP8 mice without treatment. NS. was no significant difference. SAMP8; SAMP8 control groups, SAMP8+Ex; exercise training SAMP8 groups, SAMP8+
Re; resveratrol intake SAMP8 groups, SAMP8+Ex+Re; combination exercise training and resveratrol intake SAMP8 groups. 
